Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.
A flurry of executive orders and other actions Trump issued on his first day back in office included rescinding directives by his predecessor, former President Joe Biden, that had promoted lowering drug costs and expanding coverage under the Affordable Care Act and Medicaid.
Upon his return to the United States Presidency, Donald Trump signed a number of executive orders that will not have an immediate impact, but will take effect in the coming weeks.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to negotiate, but if they don’t, they face fines or the possible end of Medicare reimbursements.
The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving greater efficiency, but a new poll from KFF shows voters largely support continued spending on Medicare and Medicaid.
· 4d · on MSN
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
Trump's early moves could actually increase drug prices for seniors
Inflation was a top issue that helped propel Donald Trump back into the White House. But actions the new president has taken in his first days on the job could hit Americans - particularly seniors - in the wallet.
Trump’s prescription drug executive order rollback didn’t quash all Biden-backed cost savings
The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.
President Donald Trump began his second administration with a blitz of policy actions to reorient U.S. government priorities.
Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and spending it on green energy subsidies.
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and Medicaid Innovation at CMS.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback